The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia.
Ya-Zhen QinQian JiangYu WangHao JiangLan-Ping XuXiao-Su ZhaoXiao-Hui ZhangKai-Yan LiuXiao-Jun HuangPublished in: Blood cancer journal (2021)